Literature DB >> 19349379

Role of the atypical cadherin Celsr3 during development of the internal capsule.

Libing Zhou1, Yibo Qu, Fadel Tissir, Andre M Goffinet.   

Abstract

The development of axonal tracts requires interactions between growth cones and the environment. Major bundles, particularly in the internal capsule, are completely defective in mice with constitutive mutation of Celsr3. In order to understand better how Celsr3 controls axonal tract formation, we generated a conditional allele that allowed inactivation of Celsr3 in different sectors of the forebrain. Effects of Celsr3 inactivation specifically in the telencephalon, in the ventral forebrain, or in the cortex, demonstrate essential roles for the gene, both in the neurons that project their axons to subcerebral targets such as the spinal cord, as well as in cells that guide projecting axons through the ventral forebrain. These observations provide unequivocal in vivo evidence that heterotypic interactions between axons and guidepost cells govern axonal path formation in mammals, and that Celsr3 plays a key role in this process. In absence of cortico-subcortical connections, mice can survive up to P20, allowing studies of behavior and cortical maturation. Mutant mice with defective corticospinal tracts survive normally and provide a model to evaluate in vivo the role of this tract in motor function in rodents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349379     DOI: 10.1093/cercor/bhp032

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  14 in total

Review 1.  Planar cell polarity genes, Celsr1-3, in neural development.

Authors:  Jia Feng; Qi Han; Libing Zhou
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

Review 2.  Mechanisms controlling the guidance of thalamocortical axons through the embryonic forebrain.

Authors:  Zoltán Molnár; Sonia Garel; Guillermina López-Bendito; Patricia Maness; David J Price
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

3.  Regulation of the protocadherin Celsr3 gene and its role in globus pallidus development and connectivity.

Authors:  Zhilian Jia; Ya Guo; Yuanxiao Tang; Quan Xu; Baojie Li; Qiang Wu
Journal:  Mol Cell Biol       Date:  2014-08-11       Impact factor: 4.272

4.  A non-autonomous function of the core PCP protein VANGL2 directs peripheral axon turning in the developing cochlea.

Authors:  Satish R Ghimire; Evan M Ratzan; Michael R Deans
Journal:  Development       Date:  2018-06-14       Impact factor: 6.868

Review 5.  Adhesion G Protein-Coupled Receptors as Drug Targets for Neurological Diseases.

Authors:  Christopher J Folts; Stefanie Giera; Tao Li; Xianhua Piao
Journal:  Trends Pharmacol Sci       Date:  2019-03-11       Impact factor: 14.819

6.  Early construction of the thalamocortical axon pathway requires c-Jun N-terminal kinase signaling within the ventral forebrain.

Authors:  Jessica G Cunningham; James D Scripter; Stephany A Nti; Eric S Tucker
Journal:  Dev Dyn       Date:  2021-09-18       Impact factor: 3.780

7.  Differential activity of Wnt/beta-catenin signaling in the embryonic mouse thalamus.

Authors:  Krista K Bluske; Yasuhiko Kawakami; Naoko Koyano-Nakagawa; Yasushi Nakagawa
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

Review 8.  Understanding cadherin EGF LAG seven-pass G-type receptors.

Authors:  Xiao-Jing Wang; Dao-Lai Zhang; Zhi-Gang Xu; Ming-Liang Ma; Wen-Bo Wang; Lin-Lin Li; Xiao-Lin Han; Yuqing Huo; Xiao Yu; Jin-Peng Sun
Journal:  J Neurochem       Date:  2014-10-26       Impact factor: 5.372

9.  Celsr3 is required for normal development of GABA circuits in the inner retina.

Authors:  Alaron Lewis; Neil Wilson; George Stearns; Nicolas Johnson; Ralph Nelson; Susan E Brockerhoff
Journal:  PLoS Genet       Date:  2011-08-11       Impact factor: 5.917

10.  Development of the corticothalamic projections.

Authors:  Eleanor Grant; Anna Hoerder-Suabedissen; Zoltán Molnár
Journal:  Front Neurosci       Date:  2012-05-04       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.